Showing results (31-40 of 42) with videos related to
Sort By:
Pageof 5
International Journal of Cancer|October 17, 2013
About 1% of the breast and ovarian Spanish families testing negative for BRCA1 and BRCA2 are carriers of RAD51D pathogenic variantsSara Gutiérrez-Enríquez, Sandra Bonache, Gorka Ruíz de Garibay, et al.Breast Cancer Research and Treatment|November 5, 2011
Detection of a large rearrangement in PALB2 in Spanish breast cancer families with male breast cancerAna Blanco, Miguel de la Hoya, Judith Balmaña, et al.Plos One|August 13, 2013
Analysis of PALB2 gene in BRCA1/BRCA2 negative Spanish hereditary breast/ovarian cancer families with pancreatic cancer casesAna Blanco, Miguel de la Hoya, Ana Osorio, et al.Breast Cancer Research and Treatment|April 17, 2009
Parity and the risk of breast and ovarian cancer in BRCA1 and BRCA2 mutation carriersRoger L Milne, Ana Osorio, Teresa Ramón y Cajal, et al.Breast Cancer Research and Treatment|May 5, 2011
Evidence for a link between TNFRSF11A and risk of breast cancerNúria Bonifaci, Marta Palafox, Pasquale Pellegrini, et al.Database : the Journal of Biological Databases and Curation|July 5, 2024
SpadaHC: a database to improve the classification of variants in hereditary cancer genes in the Spanish populationJosé M Moreno-Cabrera, Lidia Feliubadaló, Marta Pineda, et al.Human Molecular Genetics|August 7, 2009
Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriersAntonis C Antoniou, Olga M Sinilnikova, Lesley McGuffog, et al.Plos Biology|November 24, 2011
Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancerChristopher A Maxwell, Javier Benítez, Laia Gómez-Baldó, et al.Cancer Research|December 2, 2010
Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk predictionAntonis C Antoniou, Jonathan Beesley, Lesley McGuffog, et al.Human Mutation|February 16, 2018
Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutationsTimothy R Rebbeck, Tara M Friebel, Eitan Friedman, et al.Pageof 5